December 04, 2020 20:19 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
GHMC vote counting: TRS takes comfortable lead, BJP lags behind AIMIM | Mamata Banerjee speaks with protesting farmers lending support to farmers' protest | Coronavirus vaccine to be ready in next few weeks: PM Modi | India reports over 36,000 Covid-19 cases in 24 hours, 540 deaths | Three Bengal doctors, including Sagore Dutta Hospital's principal Hasi Dasgupta, succumb to COVID-19 in a single day
US FDA approves Gilead's remdesivir as COVID-19 treatment COVID19

US FDA approves Gilead's remdesivir as COVID-19 treatment

India Blooms News Service | @indiablooms | 23 Oct 2020, 10:31 am

Washington/Xinhua: The U.S. Food and Drug Administration (FDA) on Thursday approved Gilead Sciences' antiviral drug Veklury (remdesivir) as a treatment for COVID-19.

Previously authorized by the FDA for emergency use to treat COVID-19, Veklury is now the first and only approved COVID-19 treatment in the United States, said Gilead in a statement.

Veklury is indicated for adults and pediatric patients (12 years of age and older and weighing at least 40 kg) for the treatment of COVID-19 requiring hospitalization, Gilead said.

Clinical trials show Veklury shortened time to recovery by five days in hospitalized COVID-19 patients, according to the company.